Stockscreener 앱 받기
628.07
2.22%
-14.18
전일 마감가:
$642.25
열려 있는:
$643.78
하루 거래량:
607.71K
Relative Volume:
0.59
시가총액:
$65.42B
수익:
$14.25B
순이익/손실:
$4.58B
주가수익비율:
15.04
EPS:
41.7701
순현금흐름:
$3.88B
1주 성능:
-4.04%
1개월 성능:
+4.67%
6개월 성능:
+3.70%
1년 성능:
-24.23%
1일 변동 폭
$627.07
$646.22
1주일 범위
$627.07
$664.00
52주 변동 폭
$476.49
$844.51
리제네론 파마슈티컬스 Stock (REGN) Company Profile
명칭
Regeneron Pharmaceuticals Inc
전화
(914) 847-7000
주소
777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY
REGN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
REGN
Regeneron Pharmaceuticals Inc
|
628.02 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.80 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.55 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
836.27 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.19 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
리제네론 파마슈티컬스 Stock (REGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-14 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-06-30 | 다운그레이드 | Argus | Buy → Hold |
| 2025-05-30 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-05-30 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-05-14 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-04-22 | 재개 | Cantor Fitzgerald | Overweight |
| 2025-02-05 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2025-01-16 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-12-10 | 재개 | BofA Securities | Underperform |
| 2024-11-15 | 개시 | Wolfe Research | Outperform |
| 2024-11-14 | 개시 | Citigroup | Neutral |
| 2024-09-24 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-03-12 | 개시 | Bernstein | Outperform |
| 2024-01-12 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | 개시 | Deutsche Bank | Hold |
| 2023-11-03 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-08-21 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2023-08-21 | 재확인 | Oppenheimer | Perform |
| 2023-06-28 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2023-03-27 | 업그레이드 | SVB Securities | Market Perform → Outperform |
| 2023-03-24 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-03-23 | 업그레이드 | Raymond James | Underperform → Mkt Perform |
| 2023-01-30 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2023-01-20 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2022-10-26 | 다운그레이드 | Raymond James | Mkt Perform → Underperform |
| 2022-10-17 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-09-09 | 업그레이드 | Jefferies | Underperform → Hold |
| 2022-09-09 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-07-25 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2022-07-13 | 개시 | Cantor Fitzgerald | Neutral |
| 2022-06-06 | 개시 | Jefferies | Underperform |
| 2022-05-23 | 개시 | SVB Leerink | Outperform |
| 2022-01-05 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-01-03 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2021-12-15 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2021-12-09 | 재개 | Wells Fargo | Overweight |
| 2021-12-07 | 재개 | Cowen | Market Perform |
| 2021-12-06 | 개시 | Goldman | Buy |
| 2021-11-19 | 재개 | BMO Capital Markets | Outperform |
| 2021-11-05 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2021-06-29 | 개시 | H.C. Wainwright | Buy |
| 2021-01-25 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2021-01-13 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2021-01-08 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-10-05 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2020-08-20 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2020-07-09 | 업그레이드 | SunTrust | Hold → Buy |
| 2020-05-26 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2020-04-28 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-04-17 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2020-04-08 | 개시 | The Benchmark Company | Hold |
| 2020-03-31 | 개시 | Wolfe Research | Peer Perform |
| 2020-02-27 | 개시 | Barclays | Overweight |
| 2020-02-26 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2020-02-26 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-02-25 | 업그레이드 | Jefferies | Hold → Buy |
| 2020-02-11 | 업그레이드 | Argus | Hold → Buy |
| 2019-12-24 | 개시 | Raymond James | Mkt Perform |
| 2019-12-16 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-12-13 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2019-11-12 | 개시 | SunTrust | Hold |
| 2019-11-07 | 업그레이드 | Citigroup | Neutral → Buy |
| 2019-10-17 | 재개 | BofA/Merrill | Neutral |
| 2019-09-23 | 업그레이드 | Guggenheim | Neutral → Buy |
모두보기
리제네론 파마슈티컬스 주식(REGN)의 최신 뉴스
Precision Biotech Wave Builds As FDA Expedites Breakthrough Cell And Gene Therapies - TipRanks
How strong is Regeneron Pharmaceuticals Inc. stock balance sheet2025 Market Outlook & Risk Managed Investment Signals - newser.com
K.J. Harrison & Partners Inc Buys New Shares in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
How Regeneron Pharmaceuticals Inc. stock responds to policy changes2025 Trading Volume Trends & Daily Growth Stock Investment Tips - newser.com
Telos Capital Management Inc. Takes Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
South Dakota Investment Council Acquires 7,769 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
What data driven models say about Regeneron Pharmaceuticals Inc.’s futureQuarterly Performance Summary & Smart Allocation Stock Tips - newser.com
Regeneron Pharmaceuticals, Inc. $REGN Stock Holdings Trimmed by Sumitomo Life Insurance Co. - MarketBeat
News impact scoring models applied to Regeneron Pharmaceuticals Inc.July 2025 Breakouts & Safe Capital Growth Tips - newser.com
How robust is Regeneron Pharmaceuticals Inc. (RGO) stock financial positionEarnings Summary Report & Community Supported Trade Ideas - newser.com
Regeneron Pharmaceuticals, Inc. (REGN) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Regeneron Pharmaceuticals Inc. stock underperforms Monday when compared to competitors - MarketWatch
Regeneron Announces Investor Conference Presentations - The Manila Times
Regeneron to Sell Former Avon Property in Suffern - Rockland News
Can Regeneron Pharmaceuticals Inc. stock weather global recessionWeekly Trend Summary & Consistent Growth Equity Picks - newser.com
Can a trend reversal in Regeneron Pharmaceuticals Inc. lead to recoveryQuarterly Market Review & Verified Entry Point Signals - newser.com
2 Beaten-Down Stocks That Could Be About to Rally - The Globe and Mail
Intellectus Partners LLC Has $1.39 Million Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
What does recent volatility data suggest for Regeneron Pharmaceuticals Inc.Stop Loss & Weekly Top Gainers Trade List - newser.com
Cambiar Investors LLC Buys 12,160 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Triglav Investments D.O.O. Purchases Shares of 2,515 Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Why Regeneron Pharmaceuticals Inc. stock is considered a top pickMarket Risk Summary & Daily Market Momentum Tracking - newser.com
Regeneron Pharmaceuticals, Inc. $REGN Shares Sold by Lifeworks Advisors LLC - MarketBeat
Harel Insurance Investments & Financial Services Ltd. Increases Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Diabetic Retinopathy Market 2025 | Industry Developments, - openPR.com
Published on: 2025-11-03 02:40:17 - newser.com
Will earnings trigger a reversal in Regeneron Pharmaceuticals Inc.Quarterly Trade Summary & Weekly Consistent Profit Watchlists - newser.com
Heatmap analysis for Regeneron Pharmaceuticals Inc. and competitorsWeekly Trade Report & Risk Controlled Swing Alerts - newser.com
Antibody Cocktails Market See Incredible Growth 2025-2032 - openPR.com
Using fundamentals and technicals on Regeneron Pharmaceuticals Inc.Market Movement Recap & Long-Term Investment Growth Plans - newser.com
Published on: 2025-11-02 22:34:33 - newser.com
Is Regeneron Pharmaceuticals Inc. stock positioned for digital transformationWeekly Trend Report & Low Risk High Win Rate Stock Picks - newser.com
Meet the Beaten-Down Biotech Stock Cathie Wood Loves and Wall Street Says May Soar More Than 130% - The Motley Fool
AMG National Trust Bank Buys Shares of 5,969 Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Atria Investments Inc Purchases 1,442 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Flagship Harbor Advisors LLC Makes New Investment in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Arkadios Wealth Advisors Has $1.07 Million Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Oppenheimer Asset Management Inc. Purchases 643 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals (NASDAQ:REGN) Upgraded at Wall Street Zen - MarketBeat
How currency fluctuations impact Regeneron Pharmaceuticals Inc. stockForecast Cut & Technical Pattern Recognition Alerts - newser.com
Pharmaceutical Stocks To Keep An Eye OnOctober 28th - MarketBeat
Christine Poon Sells 6,500 Shares of Regeneron Pharmaceuticals (NASDAQ:REGN) Stock - MarketBeat
Combining price and volume data for Regeneron Pharmaceuticals Inc.Quarterly Portfolio Summary & Community Verified Watchlist Alerts - newser.com
Is Regeneron Pharmaceuticals Inc. trending in predictive chart modelsMarket Performance Recap & Weekly Stock Performance Updates - newser.com
Why Regeneron Pharmaceuticals Inc. (RGO) stock is listed among top recommendationsJuly 2025 Sentiment & Stock Market Timing Techniques - newser.com
Regeneron Pharmaceuticals, Inc. $REGN Shares Sold by Pinnacle Associates Ltd. - MarketBeat
Amalgamated Bank Sells 557 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Published on: 2025-11-01 03:40:36 - newser.com
Why millennials buy Regeneron Pharmaceuticals Inc. (RGO) stockMarket Trend Report & Free Technical Confirmation Trade Alerts - newser.com
Regeneron Pharmaceuticals, Inc. $REGN Stake Lessened by Brighton Jones LLC - MarketBeat
Regeneron Pharmaceuticals (REGN): Evaluating Valuation as Momentum Builds After Recent Share Price Gains - simplywall.st
리제네론 파마슈티컬스 (REGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.61%
1.30%
자본화:
|
볼륨(24시간):